Looking back to FY2017 to the most recent report, EBIT margin has been in a steady decline (17.4% down to 9.1%) If I leave out FY21 & FY22 EBIT (due to Covid) growth is at a standstill.
- Forums
- ASX - By Stock
- DMP
- Ann: Trading Update
Ann: Trading Update, page-161
Featured News
Add DMP (ASX) to my watchlist
(20min delay)
|
|||||
Last
$30.27 |
Change
-0.450(1.46%) |
Mkt cap ! $2.797B |
Open | High | Low | Value | Volume |
$30.64 | $30.69 | $30.15 | $5.355M | 176.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 9650 | $31.78 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$28.76 | 6312 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 77 | 30.230 |
4 | 258 | 30.220 |
4 | 254 | 30.210 |
4 | 261 | 30.200 |
5 | 388 | 30.190 |
Price($) | Vol. | No. |
---|---|---|
30.250 | 66 | 4 |
30.260 | 306 | 5 |
30.270 | 187 | 5 |
30.280 | 161 | 2 |
30.290 | 439 | 4 |
Last trade - 15.59pm 13/11/2024 (20 minute delay) ? |
Featured News
DMP (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online